prIME Oncology invites you to view Daily eNewsletters highlighting the most clinically relevant information presented at the 2011 Annual Hematology Meeting in San Diego.
AUDIENCE
This series of educational newsletters is intended for hematologists, oncologists, and other healthcare professionals interested in the management of patients with hematologic malignancies
EDUCATIONAL OBJECTIVES
After successful completion of this educational activity, participants should be able to:
Discuss the most recent clinical trial data regarding treatment of patients with leukemia, lymphoma, multiple myeloma, myeloproliferative neoplasms, and myelodysplastic syndromes
Describe emerging therapies and novel treatment strategies for hematologic malignancies and evaluate the practical utility of novel agents based on data from recent clinical studies
Examine recent data regarding the use of molecular markers and patient characteristics to guide the therapeutic decision-making process in patients with hematologic malignancies
Support for this activity is provided by Genentech, Incyte, and Celgene Corporation.
